New Website? I think they cloned its predecessor. It's still in the dark ages,and I can't tell the difference. I'm not trying to be negative. I think they have something better planned, but it probably hit a few more snags. My other thought is that they are in negotiations and put the remodel on hold.
Dr. Kim from Inovio said in an interview on seeking Alpha the following.
December 20, 2013
"Furthermore, one of Provenge's failures is that the product does not generate very strong T-cells against prostate antigens shown by its marginal clinical efficacy." -- Dr. Joseph Kim
Well, guess who does generate strong t-cell results against prostate cancer and has a phase 3 trial for 600 ready to rock and roll (aka: start enrolling) if they can partner it out and/or sell it outright?
Yep. NWBO.
News 
Market Data 
Discover 
AI
